Some experts worry that all the recent acquisitions will negatively affect actual care for patients. Meanwhile, the recent Cigna-Express Scripts deal is expected to draw a lengthy antitrust review.

from Kaiser Health News http://ift.tt/2GiCIAa

Related Posts:

0 comments:

Post a Comment

Popular Posts